Coronavirus Coverage

SEATTLE, WA - APRIL 17: Melissa Cruz, donates COVID-19 convalescent plasma at Bloodworks Northwest on April 17, 2020 in Seattle, Washington. Cruz contracted COVID-19 while she was a health care worker in the emergency room of Valley Medical Center in Renton, Washington about a month ago. The plasma will be used in a new experimental treatment in hopes that the antibodies will help others still battling the COVID-19 disease. The plasma donation process, called plasmapheresis, separates blood plasma, from red and white blood cells and platelets, and returns the cells and platelets back to the donor. (Photo by Karen Ducey/Getty Images)

The FDA has not approved any drugs or therapeutics to treat or prevent coronavirus, but announced guidance and recommendations for convalescent plasma treatment. In partnership with the Blood Bank of Delmarva, Beebe Healthcare is the first hospital in Delaware to offer convalescent plasma therapy as a treatment for COVID-19 patients.  According to initial studies, it is possible that plasma taken from those who have recovered, which has antibodies against the virus, could help sick patients. Current FDA guidelines allow only eligible blood donors who have recovered from COVID-19. Donors must have been asymptomatic for at least 14 days. The Blood Bank of Delmarva is asking donors to be willing to donate up to three times. If you think you are eligible to make a donation call 1-888-8BLOOD-8 or visit delmarvablood.org/cpdonor.